Global Closure Systems Exhibits at CPhI 2015
GCS’s latest innovations that will be presented at the show include standard and bespoke closures, oral dose measuring, dispensing syringes, and other medical devices.
Global Closure Systems (GCS), a supplier of plastic closure solutions, announced that it will be exhibiting at this year’s CPhI in Madrid. Its portfolio of products includes Clic-Loc, Mediloc, CapePharma, PharmaSafe, and Vistop.
GCS manufactures child-resistant closures, tamper-evident closures, droppers, and medical devices, and provides closure and dispensing solutions for liquid and solid pharmaceutical products. The company has recently extended its closures range (Flip-loc, Lite-Loc) and developed an innovative bi-injected thermoplastic elastomer closure for large-volume parenterals using blow-fill-seal technology.
Visitors at the show can learn more about GCS’s latest innovations, which include standard and bespoke closures, oral dose measuring, dispensing syringes, and other medical devices.
Source: Global Closure Systems, Booth 4F135
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
